FREE Daily Stock Alerts From Stock-PR.com
Power3 Medical Products, Inc. (OTC:PWRM)
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroProÂ®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
Although most breast cancers begin as lumps or tumors, inflammatory breast cancer usually starts with a feeling of thickness or heaviness in the breast. You also may develop red, inflamed skin on the breast.
Inflammatory breast cancer tends to grow in the form of layers or "sheets" of tissue, which doctors sometimes call "nests."
Common symptoms of inflammatory breast cancer include:
" Redness of the breast: Redness involving part or all of the breast is a hallmark of inflammatory breast cancer. Sometimes the redness comes and goes.
" Swelling of the breast: Part of or all of the breast may be swollen, enlarged, and hard.
" Warmth: The breast may feel warm.
" Orange-peel appearance: Your breast may swell and start to look like the peel of a navel orange (this is called "peau d'orange").
" Other skin changes: The skin of the breast might look pink or bruised, or you may have what looks like ridges, welts, or hives on your breast.
" Swelling of lymph nodes: The lymph nodes under your arm or above the collarbone may be swollen.
" Aching or burning: Your breast may ache or feel tender.
BC-SeraPro™ is a proteomic test for the diagnosis of breast cancer. This test is designed to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The level of the biomarkers from the patient's serum sample is compared to the Power3 Medical Products' patient database. Statistical analysis by linear discriminant function will analyze the biomarker levels of the patient sample and assign a probability score for the diagnosis of the patient sample. Probability score is ranged from 0.0 to 1.0. Results of the BC-SeraPro™ test should not be considered a standalone diagnosis nor a guarantee and is intended to be used in conjunction with mammography and other accepted modalities.
Please visit Power3 Medical Products, Inc website http://www.power3medical.com.
Tractor Supply Company (Nasdaq:TSCO) the largest retail farm and ranch store chain in the United States, announced its participation in two upcoming conferences. The Company's 30-minute presentation at the William Blair 31st Annual Growth Stock Conference will begin at 9:40 a.m. Eastern Time on Thursday, June 16, 2011. Greg Sandfort, President and Chief Merchandising Officer, and Randy Guiler, Director of Investor Relations, will attend this conference. In addition, the Company's 30-minute presentation at the NASDAQ OMX 26th Investor Program will begin at 10:30 a.m. Eastern Time on Tuesday, June 21, 2011. Jim Wright, Chairman and Chief Executive Officer, and Tony Crudele, Chief Financial Officer, will attend this conference. A webcast of both presentations will be available on the Company's website at TractorSupply.com, and an archive of each webcast will be accessible for 30 days.
Tractor Supply Company operates retail farm and ranch stores in the United States. . Tractor Supply Company was founded in 1938 and is based in Brentwood, Tennessee.
Pharmasset, Inc. (Nasdaq:VRUS) announced the addition of three treatment cohorts to the ELECTRON trial of PSI-7977, a nucleotide analog polymerase inhibitor, for the treatment of chronic hepatitis C (HCV). The rapid and consistent antiviral effects and high barrier to resistance demonstrated with PSI-7977 to date provide the rationale for additional exploratory regimens in this setting. This amendment will add one arm exploring 12 weeks of PSI-7977 monotherapy (without peginterferon and ribavirin) and two arms of interferon-sparing therapy: one for 8 weeks of PSI-7977 plus peginterferon and ribavirin (Peg-IFN/RBV) in patients with HCV genotype 2 (GT2) or 3 (GT3) and one for 12 weeks of PSI-7977 plus Peg-IFN/RBV in patients with HCV genotype 1 (GT1) prior null responses.
Pharmasset, Inc., a clinical-stage pharmaceutical company, focuses on discovering, developing, and commercializing novel drugs to treat viral infections. Pharmasset, Inc. was founded in 1998 and is based in Princeton, New Jersey.
Hansen Medical, Inc. (Nasdaq:HNSN) a global leader in flexible robotics and the developer of robotic technology for accurate 3D control of catheter movement, announced it will exhibit for the first time in the U.S. its newly branded Magellan™ Vascular Robotic System at the 2011 Vascular Annual MeetingÂ® of the Society for Vascular SurgeryÂ® from June 15-18 at McCormick Place Lakeside Center in Chicago. The Company will be exhibiting the Magellan Robotic System at Booth 229.
Hansen Medical, Inc. develops, manufactures, and markets medical robotics designed for accurate positioning, manipulation, and stable control of catheters and catheter-based technologies. Hansen Medical, Inc. was founded in 2002 and is headquartered in Mountain View, California.
Cleantech Transit Inc. (OTCPK:CLNO)
Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project can generate shareholder returns as well benefit the Company's manufacturing clients worldwide. Cleantech Transit Inc. is in the business of producing and conserving power. It produces and sells clean electricity globally, with a focus on sustainable energies using renewable resources such as Geothermal, Solar and Wind.
Cleantech Transit Inc. is pleased to provide additional details after achieving success on the 500 KW facilities and successfully moving past the interconnection testing stage.
Coming on the recent success at the 500KW facility in Merced, California this poises Phoenix Energy to become a leading developer of renewable biomass distributed generation plants that utilize local resources for local energy.
Cleantech will be providing details on the expecting closing date of its initial investment into Phoenix Energy in the coming weeks.
Biomass is biological material derived from living, or recently living organisms. In the context of biomass for energy this is often used to mean plant based material, but biomass can equally apply to both animal and vegetable derived material. The most obvious source of biomass is trees. Wood fuel can be derived from conventional forestry practice such as thinning and trimming as part of sustainable management of woodland to ensure the production of high quality timber for construction, joinery and wood products, and optimization of biodiversity.
Please visit Cleantech Transit, Inc. website www.cleantechtransitinc.com.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM). Crown Equity Holdings Inc. (OTCPK:CRWE) anticipates receiving 5,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services for Cleantech Transit, Inc. (OTCPK:CLNO).
Sign Up For Free Stock Alerts At http://stock-pr.com/signup